Visit the Orbis sponsor area

19th August 2021

Orbis: Unpacking the risks from regulatory change

For Chinese companies, regulatory change is a perennial risk. This month, the government gave investors a stark reminder of that risk when it announced sweeping changes to China’s online tutoring industry.

Amid other headlines, this led to a broad sell-off of Chinese technology stocks. We think the panic was excessive.

But regulatory risk has increased, so while we continue to find our Chinese holdings very attractive, we have resisted the urge to add materially to the Orbis Global Equity Strategy’s already-large overall exposure.

Read more

 

Important Notices

The contents of this video have been approved for issue in the United Kingdom by Orbis Investments (U.K.) Limited which is authorised and regulated by the Financial Conduct Authority. Orbis Investments (U.K.) Limited and Orbis Investments Management Limited are members of the Orbis group of companies (“Orbis”).

This video does not constitute an offer, solicitation or recommendation to buy, sell or hold any interests, shares or other securities in the companies mentioned in it. Orbis has not considered the suitability of this investment against your individual needs and risk tolerance. You must not reply upon this commentary or any part of it as investment advice and Orbis does not assume and will not accept responsibility or liability (whether arising in contract, tort, negligence or otherwise) for any error, omission, loss or damage (whether direct, indirect, consequential or otherwise) in connection with the information in this video and disclaims any such liability to the maximum extent permitted by law. This commentary has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Entities and employees of the Orbis group of companies are not subject to restrictions on dealing in relevant securities ahead of the dissemination of this review.

Past performance is not a reliable indicator of future results. When investing your capital is at risk.

Asia, Emerging Markets, Investments, Investment Commentary

Registration

Free Registration and CPD

Related Articles_

AXA IM: Can US high yield offer respite from the uncertainty?


After posting 8.2% return in 2024, the US High Yield market has proven to be very stable so far in 2025, despite various headlines with the potential to move markets on both the macro and geopolitical front.

Read More

Jupiter: Three key themes for Japan in 2022


Dan Carter and Mitesh Patel assess the outlook for Japan in 2022, from a drive for a “new capitalism” to the emerging potential of low carbon technologies.

Read More

Jupiter: Asia Pacific for income & growth – but be selective


Asia Pacific continues to provide plenty of attractive growth and income opportunities. But an active approach is key, says Jason Pidcock, Head of Strategy, Asian Income.

Read More

Login

Not yet registered?

Please complete this form to join our community

Name
Email
Company
Select your role:
Password
Confirm Password